Lisa Marie Koumoulos
Nurse Practitioner · Hackensack, NJNPI 1700482866
Payments from drug & device makers
Across 152 payments — averaging $20.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$826
- Daiichi Sankyo Inc.$349
- Lilly USA, LLC$348
- Astellas Pharma US Inc$309
- AstraZeneca$226
- Exact Sciences$183
- plus $800 from 22 others
What the payments were for
- Food & beverage$2,92596%
- Education$1164%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 44 | $826 |
| Daiichi Sankyo Inc. | 28 | $349 |
| Lilly USA, LLC | 14 | $348 |
| Astellas Pharma US Inc | 12 | $309 |
| AstraZeneca | 8 | $226 |
| Exact Sciences | 7 | $183 |
| Myriad Women's Health, Inc. | 2 | $173 |
| Inspire Medical Systems, Inc. | 4 | $78 |
| GSK | 5 | $75 |
| Medtronic | 1 | $44 |
| Pfizer | 2 | $38 |
| Bayer | 2 | $37 |
| Corcept Therapeutics | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Merck | 2 | $31 |
| Dexcom, Inc. | 2 | $30 |
| Rhythm Pharmaceuticals, Inc. | 1 | $28 |
| Boehringer Ingelheim | 2 | $28 |
| Amgen | 2 | $28 |
| AbbVie | 2 | $27 |
| Gilead | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Phadia US Inc. | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $15 |
| Intra-sana Laboratories | 1 | $15 |
| Seqirus USA Inc | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,041 in reported general payments places this provider in the 90th percentile of 2,138 nurse practitioner providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $17,392 |
| MounjaroTirzepatide | 13 | $16,700 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $15,175 |
| JardianceEmpagliflozin | 13 | $11,614 |
| Rosuvastatin Calcium | 95 | $1,763 |
| Azelastine Hcl | 47 | $1,551 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 17 | $1,138 |
| Lidocaine | 14 | $1,080 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $1,037 |
| Levothyroxine Sodium | 72 | $1,010 |
| Atorvastatin Calcium | 97 | $999 |
| Metoprolol Succinate | 43 | $703 |
| Losartan Potassium | 96 | $682 |
| Fluticasone Propionate | 53 | $623 |
| ClopidogrelClopidogrel Bisulfate | 34 | $620 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $38 | $17,39221 claims |
| Lilly USA, LLCMounjaro | $348 | $16,70013 claims |
| MerckJanumet | $31 | $15,17512 claims |
| Boehringer IngelheimJardiance | $28 | $11,61413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,138 nurse practitioner providers in New Jersey.
Other nurse practitioner in Hackensack
- Nancy ElmannHackensack$12K
- Zoya ShirHackensack$12K
- Laure PierreHackensack$8K
- Joelle GagnonHackensack$8K
- Maritess FuscoHackensack$7K
- Nancy BonnetMorristown$407K
- Vanessa CoppolaCloster$205K
- Olufunmilayo IloriUnion$133K
- Janice BeitzHaddon Heights$75K
- Adewale AdefowojuUnion$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.